AMFI - Registered Mutual Fund Distributor

Park Medi World Limited IPO

Park Medi World Limited IPO

₹ 14904 / 92 Shares Shares
Minimum Investment

Park Medi World Limited IPO

Issues Price

₹154-162 per equity share

Park Medi World Limited IPO

Open Date

10 Dec 2025

Close Date

12 Dec 2025

Lot Size

46

Min. Investment

₹ 14904

Issue Price

₹154-162

Listing Date

17 Dec 2025

Issues Size

5,67,90,123 shares(aggregating up to ₹920 crore)

Face Value

₹2 Per Equity Share

Total Shares Offered

92 Shares

Offered To Public

92 Shares

Park Medi World Limited IPO

Incorporated in 2011, Park Medi World Limited is a chain of private hospitals with the majority of its operations in North India, having a total bed capacity of 3,000 beds as of September 30, 2024. The firm has 13 multi-super speciality hospitals in its 'Park' brand. All the hospitals have NABH accreditation by the National Accreditation Board for Hospitals & Healthcare Providers, and seven are also NABL-accredited by the National Accreditation Board for Testing and Calibration Laboratories. Facilities are present in Haryana, Delhi, Punjab, and Rajasthan. The Park Hospital provides over 30 super specialty and specialty services like internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology. The hospitals have 805 intensive care unit (ICU) beds, 63 operating theatres (OTs), and an oxygen generation plant in each of them to cater to critical care.

Founded In

2011

Managing Director

Dr. Ajit Gupta

Parent Organization

Park Medi World Limited IPO

Application for Park Medi World Limited IPO

Apply as Price Range Apply Upto
Retail (min) ₹154-162 ₹14,904
Retail(max) ₹154-162 ₹1,93,752
SHNI(min) ₹154-162 ₹2,08,656
SHNI(max) ₹154-162 ₹9,98,568
BHNI(min) ₹154-162 ₹10,13,472

Apply for all eligible candidates, Park Medi World Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.9 Out of 5 (8390 Reviews)

As an NRI, I felt disconnected from Indian financial options. KSquare’s services changed that. Everything is efficient and built around my needs.

Preeti Sinha

Preeti Sinha

Social Media Strategist

Investing used to confuse me, but KSquare simplified everything. Their recommendations are tailored and backed by data. It’s been a smooth and rewarding ride so far.

Aditi Rane

Aditi Rane

Communications Officer

KSquare made the loan process so efficient that I didn’t feel stressed at all. Fantastic customer support as well.

Riya Bhattacharya

Riya Bhattacharya

Brand Consultant

KSquare not only alerts about NFOs, but they explain fund purpose and performance projections. I truly appreciate that extra layer of detail and care.

Aditya Chauhan

Aditya Chauhan

Systems Engineer

Investing in NFOs through KSquare has been a game changer. Their platform simplifies complex information and provides well-timed suggestions that fit my portfolio.

Rohan Mittal

Rohan Mittal

Financial Auditor

What I like most about KSquare is the clarity and control I have over my investments. SIPs have never been easier to manage.

Nikhil Arora

Nikhil Arora

UX Designer

I’ve tested many platforms, but KSquare stands out for their transparency and consistent performance. SIPs with them feel like a smart, hassle-free decision.

Vikram Singh

Vikram Singh

Financial Consultant

KSquare provides a transparent and smooth mutual fund experience. Their portfolio tools are user-friendly, and I love how effortless it feels to invest monthly.

Ritesh Bansal

Ritesh Bansal

Mechanical Engineer

KSquare simplified wealth creation for me. Instead of random investments, I now follow a clear long-term strategy that actually grows. Their disciplined guidance gives consistent financial confidence every month.

Rhea Fernandes

Rhea Fernandes

I was looking for a secure retirement plan, and KSquare’s NPS guidance made it very easy to start.

Richa Mahajan

Richa Mahajan

HR Advisor

FAQ's

Frequenlty Asked Question

Can I repatriate funds from my investments through KSquare?

Repatriation is allowed from NRE accounts. Investments via NRO are non-repatriable beyond set RBI limits.

Can I increase my SIP amount later?

Yes, KSquare allows you to modify or increase your SIP contributions easily as your income or goals change.

Can I have multiple SIPs for different goals?

Yes, you can set up multiple SIPs with KSquare for various goals like retirement, education, or buying a home.

How is the loan amount calculated?

The loan value is based on the mutual fund's NAV and the lender’s margin requirements. KSquare shows your eligible amount during application.

What documents are required to invest in mutual funds via KSquare?

You need a PAN card, Aadhaar, bank details, and address proof for KYC verification before starting investments.

What happens if mutual fund NAV falls after pledging?

A drop in NAV may trigger a margin call. KSquare notifies you early to take corrective actions if needed.

How does KSquare help in retirement planning?

KSquare builds long-term SIP strategies to create a secure retirement corpus based on future lifestyle, needs, and inflation.

What happens to my NPS account if I change jobs?

NPS is portable across employers, so your contributions continue seamlessly without any disruption or need for new registration.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.